vs
Side-by-side financial comparison of Allegion (ALLE) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.0B, roughly 1.5× Allegion). Allegion runs the higher net margin — 13.4% vs -13.6%, a 27.0% gap on every dollar of revenue. On growth, Allegion posted the faster year-over-year revenue change (9.7% vs -5.3%). Over the past eight quarters, Allegion's revenue compounded faster (3.5% CAGR vs -3.6%).
Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door closers, controls, and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors and door systems; and other accessories. The company sells its products and solutions to end-users in commercial, institutional, and residential facili...
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
ALLE vs OGN — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $1.5B |
| Net Profit | $138.1M | $-205.0M |
| Gross Margin | 44.0% | 49.2% |
| Operating Margin | 18.9% | -9.8% |
| Net Margin | 13.4% | -13.6% |
| Revenue YoY | 9.7% | -5.3% |
| Net Profit YoY | -6.8% | -288.1% |
| EPS (diluted) | — | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $1.1B | $1.6B | ||
| Q2 25 | $1.0B | $1.6B | ||
| Q1 25 | $941.9M | $1.5B | ||
| Q4 24 | $945.6M | $1.6B | ||
| Q3 24 | $967.1M | $1.6B | ||
| Q2 24 | $965.6M | $1.6B |
| Q1 26 | $138.1M | — | ||
| Q4 25 | $147.5M | $-205.0M | ||
| Q3 25 | $188.4M | $160.0M | ||
| Q2 25 | $159.7M | $145.0M | ||
| Q1 25 | $148.2M | $87.0M | ||
| Q4 24 | $144.1M | $109.0M | ||
| Q3 24 | $174.2M | $359.0M | ||
| Q2 24 | $155.4M | $195.0M |
| Q1 26 | 44.0% | — | ||
| Q4 25 | 44.5% | 49.2% | ||
| Q3 25 | 45.8% | 53.5% | ||
| Q2 25 | 45.6% | 54.8% | ||
| Q1 25 | 44.9% | 55.6% | ||
| Q4 24 | 44.1% | 56.3% | ||
| Q3 24 | 44.7% | 58.3% | ||
| Q2 24 | 44.4% | 58.4% |
| Q1 26 | 18.9% | — | ||
| Q4 25 | 20.3% | -9.8% | ||
| Q3 25 | 21.8% | 15.2% | ||
| Q2 25 | 21.5% | 14.4% | ||
| Q1 25 | 20.9% | 6.7% | ||
| Q4 24 | 19.5% | 8.1% | ||
| Q3 24 | 22.2% | 13.1% | ||
| Q2 24 | 21.6% | 14.6% |
| Q1 26 | 13.4% | — | ||
| Q4 25 | 14.3% | -13.6% | ||
| Q3 25 | 17.6% | 10.0% | ||
| Q2 25 | 15.6% | 9.1% | ||
| Q1 25 | 15.7% | 5.8% | ||
| Q4 24 | 15.2% | 6.8% | ||
| Q3 24 | 18.0% | 22.7% | ||
| Q2 24 | 16.1% | 12.1% |
| Q1 26 | — | — | ||
| Q4 25 | $1.70 | $-0.78 | ||
| Q3 25 | $2.18 | $0.61 | ||
| Q2 25 | $1.85 | $0.56 | ||
| Q1 25 | $1.71 | $0.33 | ||
| Q4 24 | $1.65 | $0.42 | ||
| Q3 24 | $1.99 | $1.38 | ||
| Q2 24 | $1.77 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $308.9M | $574.0M |
| Total DebtLower is stronger | $2.0B | $8.6B |
| Stockholders' EquityBook value | $2.1B | $752.0M |
| Total Assets | $5.3B | $12.9B |
| Debt / EquityLower = less leverage | 0.97× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $308.9M | — | ||
| Q4 25 | $356.2M | $574.0M | ||
| Q3 25 | $302.7M | $672.0M | ||
| Q2 25 | $656.8M | $599.0M | ||
| Q1 25 | $494.5M | $547.0M | ||
| Q4 24 | $503.8M | $675.0M | ||
| Q3 24 | $878.9M | $763.0M | ||
| Q2 24 | $747.5M | $704.0M |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $8.6B | ||
| Q3 25 | $2.1B | $8.8B | ||
| Q2 25 | $2.1B | $8.9B | ||
| Q1 25 | $2.0B | $9.0B | ||
| Q4 24 | $2.0B | $8.9B | ||
| Q3 24 | $2.4B | $8.7B | ||
| Q2 24 | $2.4B | $8.7B |
| Q1 26 | $2.1B | — | ||
| Q4 25 | $2.1B | $752.0M | ||
| Q3 25 | $1.9B | $906.0M | ||
| Q2 25 | $1.8B | $733.0M | ||
| Q1 25 | $1.6B | $542.0M | ||
| Q4 24 | $1.5B | $472.0M | ||
| Q3 24 | $1.6B | $493.0M | ||
| Q2 24 | $1.4B | $144.0M |
| Q1 26 | $5.3B | — | ||
| Q4 25 | $5.2B | $12.9B | ||
| Q3 25 | $5.2B | $13.6B | ||
| Q2 25 | $4.9B | $13.5B | ||
| Q1 25 | $4.6B | $13.2B | ||
| Q4 24 | $4.5B | $13.1B | ||
| Q3 24 | $5.0B | $12.8B | ||
| Q2 24 | $4.8B | $12.2B |
| Q1 26 | 0.97× | — | ||
| Q4 25 | 0.96× | 11.49× | ||
| Q3 25 | 1.07× | 9.74× | ||
| Q2 25 | 1.16× | 12.14× | ||
| Q1 25 | 1.24× | 16.52× | ||
| Q4 24 | 1.33× | 18.81× | ||
| Q3 24 | 1.53× | 17.75× | ||
| Q2 24 | 1.69× | 60.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $101.3M | $141.0M |
| Free Cash FlowOCF − Capex | — | $96.0M |
| FCF MarginFCF / Revenue | — | 6.4% |
| Capex IntensityCapex / Revenue | 2.0% | 3.0% |
| Cash ConversionOCF / Net Profit | 0.73× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $101.3M | — | ||
| Q4 25 | $240.1M | $141.0M | ||
| Q3 25 | $229.5M | $264.0M | ||
| Q2 25 | $209.7M | $220.0M | ||
| Q1 25 | $104.5M | $75.0M | ||
| Q4 24 | $219.0M | $390.0M | ||
| Q3 24 | $231.9M | $141.0M | ||
| Q2 24 | $173.0M | $332.0M |
| Q1 26 | — | — | ||
| Q4 25 | $200.5M | $96.0M | ||
| Q3 25 | $209.8M | $218.0M | ||
| Q2 25 | $192.0M | $181.0M | ||
| Q1 25 | $83.4M | $43.0M | ||
| Q4 24 | $194.9M | $335.0M | ||
| Q3 24 | $212.0M | $99.0M | ||
| Q2 24 | $152.1M | $300.0M |
| Q1 26 | — | — | ||
| Q4 25 | 19.4% | 6.4% | ||
| Q3 25 | 19.6% | 13.6% | ||
| Q2 25 | 18.8% | 11.4% | ||
| Q1 25 | 8.9% | 2.8% | ||
| Q4 24 | 20.6% | 21.0% | ||
| Q3 24 | 21.9% | 6.3% | ||
| Q2 24 | 15.8% | 18.7% |
| Q1 26 | 2.0% | — | ||
| Q4 25 | 3.8% | 3.0% | ||
| Q3 25 | 1.8% | 2.9% | ||
| Q2 25 | 1.7% | 2.4% | ||
| Q1 25 | 2.2% | 2.1% | ||
| Q4 24 | 2.5% | 3.5% | ||
| Q3 24 | 2.1% | 2.7% | ||
| Q2 24 | 2.2% | 2.0% |
| Q1 26 | 0.73× | — | ||
| Q4 25 | 1.63× | — | ||
| Q3 25 | 1.22× | 1.65× | ||
| Q2 25 | 1.31× | 1.52× | ||
| Q1 25 | 0.71× | 0.86× | ||
| Q4 24 | 1.52× | 3.58× | ||
| Q3 24 | 1.33× | 0.39× | ||
| Q2 24 | 1.11× | 1.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALLE
| Allegion Americas | $809.9M | 78% |
| Allegion International | $223.7M | 22% |
OGN
Segment breakdown not available.
